Hypertension Trial, Recruiting NCT00932139 Sponsor: University of California, Irvine Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT00932139
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have mild coronary (heart) disease and no significant abnormalities on a resting heart tracing (ECG) that would suggest reduced blood flow to the heart.
  • People who have high blood pressure, whether or not they are currently taking medication to manage it.

Who may not be able to join:

  • Women who are pregnant or breastfeeding.
  • People who have severe coronary (heart) disease, including continuous chest pain (angina).
  • People whose heart tracing (ECG) shows a specific electrical conduction problem in the heart known as left bundle branch block.
  • People who have irregular heart rhythms that are associated with low blood pressure (below 90 mmHg).
  • People who have disease affecting the blood vessels in their limbs (peripheral vascular disease).
  • People who have a bone or joint condition (orthopedic disease) that could affect their ability to exercise safely.
  • People who have diabetes or a psychological condition that could make it unsafe for them to participate in exercise or stress testing as part of this trial.
  • People who are known to have sensitive skin or strong reactions to skin creams, medical dressings, or skin tapes.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Shaista Malik, MD, PhD, MPH, University of California, Irvine

Phone: 9494005909

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of California, Irvine
Registry
ClinicalTrials.gov
Start date
1 February 2003
Est. completion
1 September 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

blood pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov